Tag: bioequivalence
- Apr 9, 2026
- Posted by Cillian Osterfield
Drug Interactions: Are Generic and Brand-Name Medications Equally Safe?
Do generic drugs carry more interaction risks than brand-name versions? Discover why the active ingredients make the risk identical and where the real differences lie.
- Mar 1, 2026
- Posted by Cillian Osterfield
IVIVC and Waivers: How In Vitro Testing Replaces In Vivo Bioequivalence Studies
IVIVC lets regulators approve generic drugs without human trials by linking lab dissolution data to real-world absorption. Learn how Level A correlation saves millions and why most submissions fail.
- Feb 1, 2026
- Posted by Cillian Osterfield
Partial AUC: Advanced Bioequivalence Measurements Explained
Partial AUC is an advanced bioequivalence tool that measures drug exposure during key time windows, ensuring complex generics like extended-release painkillers match brand-name performance. It catches differences traditional metrics miss.
- Dec 28, 2025
- Posted by Cillian Osterfield
Long-Term Health After Switching to Generics: What Really Happens After a Year?
Switching to generic medications saves money, but long-term health outcomes aren't always guaranteed. Learn how manufacturing differences, frequent switches, and lack of long-term data can affect stability-and what you can do to protect your health.
